Brought to you by 
Syros nets $53.5mm through IPO
07 Jul 2016
Executive Summary
Syros Pharmaceuticals Inc. (oncology) netted $53.5mm through its initial public offering of 4.6mm common shares (including the overallotment) at $12.50. The company filed in early June, hoping to sell 4mm shares between $14-16, and closed the offering less than a month later.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Syros nets $53.5mm through IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice